Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prescribe to Prevent HIV (P2PH): Enhancing Clinic-based Prescribing of Harm Reduction: A Clinical Trial to Prevent HIV and Severe Injection-related Infections Among PWID

NCT07073924 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT07073924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07073924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prescribe to Prevent HIV (P2PH): Enhancing Clinic-based Prescribing of Harm Reduction: A Clinical Trial to Prevent HIV and Severe Injection-related Infections Among PWID
Lead sponsor
University of Pittsburgh
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
June 30, 2028
Enrollment
536 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

people who use opioids/people with opioid use disorder (oud)